Real-world evidence for postmenopausal women with HR+, HER2- advanced breast cancer (aBC) treated with alpelisib (ALP): RIBANNA study protocol update

M Schmidt; Cosima Brucker; T Decker; J Falbrede; P Fasching; H Forstbauer; T Göhler; O Hoffmann; C Jackisch; j Janssen; A Köhler; K Lüdtke-Heckenkamp; D Lüftner; F Marme; A Nusch; T Reimer; C Roos; Weide

Real-world evidence for postmenopausal women with HR+, HER2- advanced breast cancer (aBC) treated with alpelisib (ALP): RIBANNA study protocol update

M Schmidt
, Cosima Brucker
, T Decker
, J Falbrede
, P Fasching
, H Forstbauer
, T Göhler
, O Hoffmann
, C Jackisch
, j Janssen
, A Köhler
, K Lüdtke-Heckenkamp
, D Lüftner
, F Marme
, A Nusch
, T Reimer
, C Roos
, Weide

Department of Gynaecology and Obstetrics

Research output: Contribution to conference › Abstract

Original language	Undefined/Unknown
Publication status	Published - 2020
Event	SABCS - Virtuell Duration: 8 Dec 2020 → 12 Dec 2020

Conference with scientific content

Conference with scientific content	SABCS
City	Virtuell
Period	8/12/20 → 12/12/20

Real-world evidence for postmenopausal women with HR+, HER2- advanced breast cancer (aBC) treated with alpelisib (ALP): RIBANNA study protocol update
Schmidt, M., Brucker, C., Decker, T., Falbrede, J., Fasching, P., Forstbauer, H., Göhler, T., Hoffmann, O., Jackisch, C., Janssen, J., Köhler, A., Lüdtke-Heckenkamp, K., Lüftner, D., Marme, F., Nusch, A., Reimer, T., Roos, C. & Weide, 2020.
Research output: Contribution to conference › Poster

Cite this

Schmidt, M., Brucker, C., Decker, T., Falbrede, J., Fasching, P., Forstbauer, H., Göhler, T., Hoffmann, O., Jackisch, C., Janssen, J., Köhler, A., Lüdtke-Heckenkamp, K., Lüftner, D., Marme, F., Nusch, A., Reimer, T., Roos, C., & Weide (2020). Real-world evidence for postmenopausal women with HR+, HER2- advanced breast cancer (aBC) treated with alpelisib (ALP): RIBANNA study protocol update. Abstract from SABCS, Virtuell.

@conference{119461cef3f447b2ad8862da6ca16ed6,

title = "Real-world evidence for postmenopausal women with HR+, HER2- advanced breast cancer (aBC) treated with alpelisib (ALP): RIBANNA study protocol update",

author = "M Schmidt and Cosima Brucker and T Decker and J Falbrede and P Fasching and H Forstbauer and T G{\"o}hler and O Hoffmann and C Jackisch and j Janssen and A K{\"o}hler and K L{\"u}dtke-Heckenkamp and D L{\"u}ftner and F Marme and A Nusch and T Reimer and C Roos and Weide",

year = "2020",

language = "Undefined/Unknown",

note = "SABCS ; Conference date: 08-12-2020 Through 12-12-2020",

}

Schmidt, M, Brucker, C, Decker, T, Falbrede, J, Fasching, P, Forstbauer, H, Göhler, T, Hoffmann, O, Jackisch, C, Janssen, J, Köhler, A, Lüdtke-Heckenkamp, K, Lüftner, D, Marme, F, Nusch, A, Reimer, T, Roos, C & Weide 2020, 'Real-world evidence for postmenopausal women with HR+, HER2- advanced breast cancer (aBC) treated with alpelisib (ALP): RIBANNA study protocol update', SABCS, Virtuell, 8/12/20 - 12/12/20.

TY - CONF

T1 - Real-world evidence for postmenopausal women with HR+, HER2- advanced breast cancer (aBC) treated with alpelisib (ALP): RIBANNA study protocol update

AU - Schmidt, M

AU - Brucker, Cosima

AU - Decker, T

AU - Falbrede, J

AU - Fasching, P

AU - Forstbauer, H

AU - Göhler, T

AU - Hoffmann, O

AU - Jackisch, C

AU - Janssen, j

AU - Köhler, A

AU - Lüdtke-Heckenkamp, K

AU - Lüftner, D

AU - Marme, F

AU - Nusch, A

AU - Reimer, T

AU - Roos, C

AU - Weide, null

PY - 2020

Y1 - 2020

M3 - Abstrakt

T2 - SABCS

Y2 - 8 December 2020 through 12 December 2020

ER -